Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2026

Norepinephrine Versus Vasopressin as First-Line Vasopressor Therapy in Septic Shock: Implications for Patients Presenting to the Emergency Department

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMazi Mohammed AlanaziHAHadi Saleh Hadi AlyamiMAMaha Sameer Turki Almutairi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Alanazi et al. (2026) studied this question.

synapsesocial.com/papers/6aabb7155f706d05830e5ea1https://doi.org/10.65759/aszttx19
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical efficacy and safety of vasopressin and its analogues in patients with septic shock: a meta-analysis and trial sequential analysis2024
  2. 2A Systematic Review and Meta-Analysis of the Timing of Vasopressor Therapy in Patients with Septic Shock: Assessing Clinical Outcomes and Implication2024
  3. 3Optimizing Timing and Dose of Starting Norepinephrine and Vasopressin in Septic Shock2026
  4. 4Comparison of short-term and long-term renal function effects of vasopressin and norepinephrine in patients with septic shock: a systematic review and meta-analysis2025
  5. 5Vasopressor therapy for septic shock after adequate fluid resuscitation in the emergency department: a systematic review and meta-analysis2026